In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

The Washington Post covers efforts by insurers to clamp down on doctors prescribing Ozempic, now popular as a weight loss drug, for patients who don't evidently present with diabetes. Separately, CBS ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

"MEDVi," a sketchy online market for GLP-1 drugs, is using AI to spin up terrible ads — and, insidiously, to deepfake ...